Astal Laboratories responded to BSE's inquiry regarding significant stock price movement in its scrip.
The company attributed the price movement solely to market conditions and denied any undisclosed material information.
Management confirmed full compliance with SEBI Listing Regulations regarding all material disclosures.
The company stated no knowledge of specific reasons behind the recent price volatility.